Error! You must javascript enabled to use this form. Please enable Javascript in your browser. Rexahn CEO Dr. Peter Suzdak Interviewed on CorporateProfile.com Corporate Profile, LLC announced today that Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), CEO Dr. Peter Suzdak was interviewed on www.CorporateProfile.com. View full press release Your Name: Your Email: Subject: Question: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send